APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Research Report 2026

23 December 2025136 pages

Choose your research edition.

Industry ResearchChronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) include Abbott, Takeda, Fresenius, Amgen, Abbvie, Vifor, Spectrum, Shield and Sanofi Genzyme, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Company

Abbott

Takeda

Fresenius

Amgen

Abbvie

Vifor

Spectrum

Shield

Sanofi Genzyme

OPKO

Novadiol

Japan Tobacco Company

Daiichi-Sankyo

Astellas

Ardelyx

Akebia

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Type

Maintain Blood Calcium Levels

Control Hyperphosphatemia

Control PTH Level

Correct Acidosis

Others

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application

Hospital Pharmacies

Drug Stores

Online Pharmacies

Retail Pharmacies

Others

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons) of Manufacturers (2021-2026) Table 7. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue of Manufacturers (2021-2026) Table 9. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Price (US$/kg) of Manufacturers (2021-2026) Table 11. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Product Type & Application Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Abbott Company Information Table 19. Abbott Business Overview Table 20. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 21. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 22. Abbott Recent Developments Table 23. Takeda Company Information Table 24. Takeda Business Overview Table 25. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 26. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 27. Takeda Recent Developments Table 28. Fresenius Company Information Table 29. Fresenius Business Overview Table 30. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 31. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 32. Fresenius Recent Developments Table 33. Amgen Company Information Table 34. Amgen Business Overview Table 35. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 36. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 37. Amgen Recent Developments Table 38. Abbvie Company Information Table 39. Abbvie Business Overview Table 40. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 41. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 42. Abbvie Recent Developments Table 43. Vifor Company Information Table 44. Vifor Business Overview Table 45. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 46. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 47. Vifor Recent Developments Table 48. Spectrum Company Information Table 49. Spectrum Business Overview Table 50. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 51. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 52. Spectrum Recent Developments Table 53. Shield Company Information Table 54. Shield Business Overview Table 55. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 56. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 57. Shield Recent Developments Table 58. Sanofi Genzyme Company Information Table 59. Sanofi Genzyme Business Overview Table 60. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 61. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 62. Sanofi Genzyme Recent Developments Table 63. OPKO Company Information Table 64. OPKO Business Overview Table 65. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 66. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 67. OPKO Recent Developments Table 68. Novadiol Company Information Table 69. Novadiol Business Overview Table 70. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 71. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 72. Novadiol Recent Developments Table 73. Japan Tobacco Company Company Information Table 74. Japan Tobacco Company Business Overview Table 75. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 77. Japan Tobacco Company Recent Developments Table 78. Daiichi-Sankyo Company Information Table 79. Daiichi-Sankyo Business Overview Table 80. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 82. Daiichi-Sankyo Recent Developments Table 83. Astellas Company Information Table 84. Astellas Business Overview Table 85. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 87. Astellas Recent Developments Table 88. Ardelyx Company Information Table 89. Ardelyx Business Overview Table 90. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 91. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 92. Ardelyx Recent Developments Table 93. Akebia Company Information Table 94. Akebia Business Overview Table 95. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 96. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 97. Akebia Recent Developments Table 98. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2021-2026) & (tons) Table 100. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2021-2026) Table 101. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2027-2032) & (tons) Table 102. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2027-2032) Table 103. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2021-2026) Table 105. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2027-2032) Table 107. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 109. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2027-2032) & (tons) Table 110. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 114. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2027-2032) & (tons) Table 115. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 119. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2027-2032) & (tons) Table 120. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 124. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2027-2032) & (tons) Table 125. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 129. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2027-2032) & (tons) Table 130. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (tons) Table 133. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2027-2032) & (tons) Table 134. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2021-2026) Table 135. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2027-2032) Table 136. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2021-2026) Table 139. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2027-2032) Table 140. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2021-2026) & (US$/kg) Table 141. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2027-2032) & (US$/kg) Table 142. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (tons) Table 143. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2027-2032) & (tons) Table 144. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2021-2026) Table 145. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2027-2032) Table 146. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2021-2026) Table 149. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2027-2032) Table 150. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2021-2026) & (US$/kg) Table 151. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2027-2032) & (US$/kg) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List Table 155. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers List Table 156. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Trends Table 157. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Drivers Table 158. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Image Figure 5. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size (2021-2032) & (US$ Million) Figure 7. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (2021-2032) & (tons) Figure 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Price (US$/kg) & (2021-2032) Figure 9. Maintain Blood Calcium Levels Product Image Figure 10. Control Hyperphosphatemia Product Image Figure 11. Control PTH Level Product Image Figure 12. Correct Acidosis Product Image Figure 13. Others Product Image Figure 14. Hospital Pharmacies Product Image Figure 15. Drug Stores Product Image Figure 16. Online Pharmacies Product Image Figure 17. Retail Pharmacies Product Image Figure 18. Others Product Image Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region in 2025 Figure 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region in 2025 Figure 26. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country in 2025 Figure 27. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2032) Figure 28. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2021-2032) Figure 29. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country in 2025 Figure 33. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2032) Figure 34. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2021-2032) Figure 35. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Spain Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Netherlands Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Switzerland Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Sweden Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Poland Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country in 2025 Figure 46. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2032) Figure 47. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2021-2032) Figure 48. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country in 2025 Figure 57. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2032) Figure 58. South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2021-2032) Figure 59. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Chile Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country in 2025 Figure 63. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2032) Figure 64. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2021-2032) Figure 65. Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Israel Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Türkiye Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. GCC Countries Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2021-2032) Figure 71. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2021-2032) Figure 72. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (US$/kg) by Type (2021-2032) Figure 73. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2021-2032) Figure 74. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2021-2032) Figure 75. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (US$/kg) by Application (2021-2032) Figure 76. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value Chain Figure 77. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Maintain Blood Calcium Levels
  • Control Hyperphosphatemia
  • Control PTH Level
  • Correct Acidosis
  • Others
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Abbott
  • Takeda
  • Fresenius
  • Amgen
  • Abbvie
  • Vifor
  • Spectrum
  • Shield
  • Sanofi Genzyme
  • OPKO
  • Novadiol
  • Japan Tobacco Company
  • Daiichi-Sankyo
  • Astellas
  • Ardelyx
  • Akebia

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size (2021-2032)
  4. 2.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (2021-2032)
  5. 2.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Average Price (2021-2032)
  6. 2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Maintain Blood Calcium Levels
  9. 2.3.3 Control Hyperphosphatemia
  10. 2.3.4 Control PTH Level
  11. 2.3.5 Correct Acidosis
  12. 2.3.6 Others
  13. 2.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Hospital Pharmacies
  16. 2.4.3 Drug Stores
  17. 2.4.4 Online Pharmacies
  18. 2.4.5 Retail Pharmacies
  19. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons) of Manufacturers (2021-2026)
  3. 3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Product Type & Application
  8. 3.8 Global Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Established Date
  9. 3.9 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Abbott
  2. 4.1.1 Abbott Company Information
  3. 4.1.2 Abbott Business Overview
  4. 4.1.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  6. 4.1.5 Abbott Recent Developments
  7. 4.2 Takeda
  8. 4.2.1 Takeda Company Information
  9. 4.2.2 Takeda Business Overview
  10. 4.2.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  12. 4.2.5 Takeda Recent Developments
  13. 4.3 Fresenius
  14. 4.3.1 Fresenius Company Information
  15. 4.3.2 Fresenius Business Overview
  16. 4.3.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  18. 4.3.5 Fresenius Recent Developments
  19. 4.4 Amgen
  20. 4.4.1 Amgen Company Information
  21. 4.4.2 Amgen Business Overview
  22. 4.4.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  24. 4.4.5 Amgen Recent Developments
  25. 4.5 Abbvie
  26. 4.5.1 Abbvie Company Information
  27. 4.5.2 Abbvie Business Overview
  28. 4.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  30. 4.5.5 Abbvie Recent Developments
  31. 4.6 Vifor
  32. 4.6.1 Vifor Company Information
  33. 4.6.2 Vifor Business Overview
  34. 4.6.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  36. 4.6.5 Vifor Recent Developments
  37. 4.7 Spectrum
  38. 4.7.1 Spectrum Company Information
  39. 4.7.2 Spectrum Business Overview
  40. 4.7.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  42. 4.7.5 Spectrum Recent Developments
  43. 4.8 Shield
  44. 4.8.1 Shield Company Information
  45. 4.8.2 Shield Business Overview
  46. 4.8.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  48. 4.8.5 Shield Recent Developments
  49. 4.9 Sanofi Genzyme
  50. 4.9.1 Sanofi Genzyme Company Information
  51. 4.9.2 Sanofi Genzyme Business Overview
  52. 4.9.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  54. 4.9.5 Sanofi Genzyme Recent Developments
  55. 4.10 OPKO
  56. 4.10.1 OPKO Company Information
  57. 4.10.2 OPKO Business Overview
  58. 4.10.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  60. 4.10.5 OPKO Recent Developments
  61. 4.11 Novadiol
  62. 4.11.1 Novadiol Company Information
  63. 4.11.2 Novadiol Business Overview
  64. 4.11.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  66. 4.11.5 Novadiol Recent Developments
  67. 4.12 Japan Tobacco Company
  68. 4.12.1 Japan Tobacco Company Company Information
  69. 4.12.2 Japan Tobacco Company Business Overview
  70. 4.12.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  72. 4.12.5 Japan Tobacco Company Recent Developments
  73. 4.13 Daiichi-Sankyo
  74. 4.13.1 Daiichi-Sankyo Company Information
  75. 4.13.2 Daiichi-Sankyo Business Overview
  76. 4.13.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  78. 4.13.5 Daiichi-Sankyo Recent Developments
  79. 4.14 Astellas
  80. 4.14.1 Astellas Company Information
  81. 4.14.2 Astellas Business Overview
  82. 4.14.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  84. 4.14.5 Astellas Recent Developments
  85. 4.15 Ardelyx
  86. 4.15.1 Ardelyx Company Information
  87. 4.15.2 Ardelyx Business Overview
  88. 4.15.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  90. 4.15.5 Ardelyx Recent Developments
  91. 4.16 Akebia
  92. 4.16.1 Akebia Company Information
  93. 4.16.2 Akebia Business Overview
  94. 4.16.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  96. 4.16.5 Akebia Recent Developments
5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Scenario by Region
  1. 5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region: 2021-2032
  3. 5.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region: 2021-2026
  4. 5.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region: 2027-2032
  5. 5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2021-2032
  6. 5.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2021-2026
  7. 5.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2027-2032
  8. 5.4 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
  9. 5.4.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2032)
  11. 5.4.3 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
  16. 5.5.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2032)
  18. 5.5.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
  41. 5.7.1 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2032)
  43. 5.7.3 South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2032)
  2. 6.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2032) & (tons)
  3. 6.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2021-2032)
  5. 6.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2032)
  2. 7.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2032) & (tons)
  3. 7.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2021-2032)
  5. 7.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value Chain Analysis
  2. 8.1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Mode & Process
  5. 8.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
  8. 8.2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers
9 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Analyzing Market Dynamics
  1. 9.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Trends
  2. 9.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Drivers
  3. 9.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Opportunities and Challenges
  4. 9.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst